HeartFlow is a series c plus startup based in United States. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
HeartFlow is a medical technology company focused on revolutionizing the treatment of coronary artery disease. Their non-invasive HeartFlow FFRct Analysis leverages advanced technology to create a personalized 3D model of the coronary arteries, providing valuable insights to physicians for diagnosis and treatment planning.
Stage
series-c-plus
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky